Future of Pharmacy

The Ensuring Community Access to Pharmacist Services (ECAPS) Act would enhance Medicare coverage for pharmacist services and ensure seniors can access essential care in underserved areas.

The coronary artery disease (CAD) predictive model help health care professionals tailor personalized treatment methods for patients.

AI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care.

SOC emphasizes adaptability and individual professional judgment without compromising quality, as individuals are held to the standard and expertise of their practice area.

The future holds the promise of earlier diagnosis, more targeted therapies, and personalized neurological care, said speaker William D. Freeman, MD, FAAN.

Similar legislation could also address PBM practices in commercial insurance.

How PBMs Are Reshaping Access, Affordability, and Outcomes in Modern Health Care

Wafa Samara, PharmD, vice president and chief pharmacy officer at City of Hope, highlights the vital role of oncology pharmacists at City of Hope in improving patient outcomes, conducting and leading research, and working as integral members of the multidisciplinary care team.

Amir Ali, PharmD, BCOP, discusses his experience as an oncology pharmacist in both direct and indirect patient care at the University of Southern California (USC) Norris Comprehensive Cancer Center.

A pilot program integrated oncology pharmacists into prior authorization workflows to streamline and expedite medication approvals.

Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.

Unlike other professionals such as nurses and physicians, pharmacists remain tethered to a fragmented state-by-state licensure model that creates unnecessary barriers to care.

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.

Notable advancements include machine learning and predictive analytics, among others.

Amazon Pharmacy’s subscription service could cause sale disruptions for traditional retail pharmacies.

The speed and scale of what’s coming with AI can only be imagined now, but without a doubt, our lives will change.

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.

The caps on insulin and yearly out-of-pocket drug costs remain unaffected by this decision.

These drugs are set to revolutionize their respective disease states in 2025.

Rite Aid survey highlights underutilized role of pharmacists in health care, with 62% of respondents viewing their pharmacists as a crucial part of their health and wellness care team.

Jim Dente of Advanced Pharmacy Solutions emphasizes the growing role of automation, artificial intelligence, and patient-centric business models in streamlining operations, improving patient care, and addressing industry challenges such as staff burnout and medication errors.

The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.

The new Medicare cap limits out-of-pocket drug costs to $2000 annually.

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.

Exponential growth in development is unsustainable in biological systems. But what about AI?

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists’ value within the health care system.